.Attributes Medication, Published online: 16 Oct 2024 doi:10.1038/ s41591-024-03348-1Publisher Correction: Allogeneic CD5-specific CAR-T treatment for relapsed/refractory T-ALL: a period 1 test.
Your daily update on everything worldwide—from news and finance to technology, health, and lifestyle.
.Attributes Medication, Published online: 16 Oct 2024 doi:10.1038/ s41591-024-03348-1Publisher Correction: Allogeneic CD5-specific CAR-T treatment for relapsed/refractory T-ALL: a period 1 test.